KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Net Margin (2016 - 2025)

Historic Net Margin for Inovio Pharmaceuticals (INO) over the last 17 years, with Q1 2025 value amounting to 37100.3%.

  • Inovio Pharmaceuticals' Net Margin changed N/A to 37100.3% in Q1 2025 from the same period last year, while for Sep 2025 it was 47654.43%, marking a year-over-year increase of 80433000.0%. This contributed to the annual value of 49509.43% for FY2024, which is 332695600.0% down from last year.
  • According to the latest figures from Q1 2025, Inovio Pharmaceuticals' Net Margin is 37100.3%.
  • Over the past 5 years, Inovio Pharmaceuticals' Net Margin peaked at 412.75% during Q3 2022, and registered a low of 43687.24% during Q4 2022.
  • For the 5-year period, Inovio Pharmaceuticals' Net Margin averaged around 22946.68%, with its median value being 20627.17% (2021).
  • Examining YoY changes over the last 5 years, Inovio Pharmaceuticals' Net Margin showed a top increase of 202144200bps in 2022 and a maximum decrease of -309419600bps in 2022.
  • Over the past 5 years, Inovio Pharmaceuticals' Net Margin (Quarter) stood at 12745.28% in 2021, then plummeted by -243bps to 43687.24% in 2022, then skyrocketed by 44bps to 24357.91% in 2023, then surged by 32bps to 16682.03% in 2024, then crashed by -122bps to 37100.3% in 2025.
  • Its Net Margin was 37100.3% in Q1 2025, compared to 16682.03% in Q4 2024 and 31648.39% in Q2 2024.